Makati Medical Center, also known as Makati Med, is a tertiary hospital in Makati, Metro Manila, Philippines with more than 600 beds. The hospital was founded on May 31, 1969.

During the past decade, Makati Medical Center conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 12 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 7 clinical trials were completed. i.e. 41.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Makati Medical Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Makati Medical Center" with 2 trials sponsored and "Philippine Neurological Association" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Makati Medical Center" #1 collaborator was "A. Menarini Philippines, Inc." with 1 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Baguio General Hospital and Medical Center, Philippines" with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Makati Medical Center" are "Covid19" (2 trials), "Lung Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Adenocarcinoma" (1 trials). Many other conditions were trialed in "Makati Medical Center" in a lesser frequency.

Most popular intervention types in "Makati Medical Center" are "Drug" (27 trials), "Other" (7 trials), "Biological" (4 trials), "Combination Product" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Pemetrexed" (3 trials) and "ATM-AVI" (2 trials). Other intervention names were less common.

The vast majority of trials in "Makati Medical Center" are 36 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Makati Medical Center". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Makati Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Makati Medical Center, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".